Re-entry of Guangji Pharma's VB2 into EU market to be benefited by European Commission's new regulation

Summary: Issued by European Commission, the Commission Implementing Regulation (EU) 2023/651, which concerns the authorisation of riboflavin (vitamin B2) produced by Bacillus subtilis KCCM 10445 and a preparation of riboflavin produced by B. subtilis...

Vitamins China E-News 202304

www.cnchemicals.com